Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/09/2003CA2480633A1 Neurotrophic and neuroprotective peptides
10/09/2003CA2480630A1 Tissue treatment
10/09/2003CA2480626A1 Enhancement of endogenous gonadotropin production
10/09/2003CA2480554A1 Bone generation by gene therapy
10/09/2003CA2480419A1 Antiopoietin-related growth factor
10/09/2003CA2480386A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/09/2003CA2480377A1 Drug microparticles
10/09/2003CA2480372A1 Combination therapy using trefoil peptides
10/09/2003CA2480265A1 Cochleates made with purified soy phosphatidylserine
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2480141A1 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003CA2480138A1 Transcellular drug delivery system
10/09/2003CA2480128A1 Methods of using flt3-ligand in immunization protocols
10/09/2003CA2480047A1 Use of rom production and release inhibitors to treat and prevent intraocular damage
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479807A1 Antimicrobial polymer conjugates
10/09/2003CA2479763A1 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003CA2479759A1 Protamine-adenoviral vector complexes and methods of use
10/09/2003CA2479750A1 Fibrinogen binding moieties
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003CA2476288A1 Enzyme disruption of bacterial biofilms
10/09/2003CA2469720A1 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays
10/08/2003EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays
10/08/2003EP1350525A2 Matrix-free osteogenic devices, implants and methods thereof
10/08/2003EP1350521A1 Immunotherapeutic combinations for the treatment of tumors
10/08/2003EP1350520A1 Human transferrin for treatment of anaemia of chronic disease (ACD) and functional iron deficiency
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350518A1 Prolonged release of GM-CSF
10/08/2003EP1350517A1 Analogues of dipeptide citrullinylarginine and their dermatological use as care and treatment agents
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1350113A2 Inhibition of cmv infection and dissemination
10/08/2003EP1350104A2 Presenilin enhancers
10/08/2003EP1349964A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349942A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
10/08/2003EP1349940A2 55562 and 21617, novel human proteins and methods of use thereof
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349934A2 Compositions and methods relating to breast specific genes and proteins
10/08/2003EP1349933A2 Proteins and dna sequences underlying these proteins used for treating inflammations
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349929A2 Apoptosis-inducing dna sequences
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349922A2 Regulation of target protein activity through modified proteins
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349874A2 Peptide and polypeptide inhibitors of complement c1s
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349872A2 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349589A1 A device and a method for dispensing at least two mutually reactive components
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349576A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological di
10/08/2003EP1349575A2 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349566A2 Methods for ameliorating childhood infections
10/08/2003EP1349565A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
10/08/2003EP1349564A2 Regulation of cellproliferation and differentiation using topically applied peptides
10/08/2003EP1349563A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349555A1 Treatment of cancer by reduction of intracellular energy and pyrimidines
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349457A1 Liquid antimicrobial compositions
10/08/2003EP1272230B1 Injectable bone mineral substitute material comprising bone cement and oil
10/08/2003EP1207901B1 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections
10/08/2003EP1165119B1 Composition based on oppositely-charged polypeptides
10/08/2003EP1140018B1 Polyol/oil suspensions for the sustained release of proteins
10/08/2003EP1100530B1 In-vitro stimulation of beta cell proliferation
10/08/2003EP1073455B1 Compositions and methods for extending the action of clostridial neurotoxin
10/08/2003EP0971725B1 Methods for treatment of scar tissue
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0819010B1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous sucrose solution
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003EP0650364B1 Purification of factor ix
10/08/2003EP0607392B1 Plasma fraction purification
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447920A Compsns. and methods for modulating tumor specific expression
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447818A Anti-heparin peptides
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1447696A Gene detection assay for improving likelihood of effective response to erbb antagonist cancer therapy
10/08/2003CN1446912A Reformed lyophylization preparation of recombinant staphylokinase (r-Sak), its preparing method and application
10/08/2003CN1446824A Vasoconstriction factor and preparation method as well as its application in pharmacy
10/08/2003CN1446822A Acidic antibacterial peptides and gene as well as its application in pharmacy
10/08/2003CN1446821A Active antibiotics dodeca peptide
10/08/2003CN1446582A Preparation for eyes
10/08/2003CN1446581A Coupling object between CB and biological active peptide or immunoglobhulin or immunological activity original as well as medication usage
10/08/2003CN1123639C Human activated protein C and its prepn. process
10/08/2003CN1123574C Ligands for FLT3 receptors
10/08/2003CN1123360C Inhibitors of cyclophilin rotamase activity
1 ... 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 ... 3163